According to the Commission, Sanofi’s Dengvaxia vaccine is only indicated for the population from 9 years old to 45 years old.
POLITICAL ANIMAL. – The Federal Commission for the Protection against Health Risks (Cofepris) alerted general practitioners, nursing staff and pediatricians about the risks of using the dengue vaccine.
Through a statement, the Commission said that the announcement was made after detecting that the vaccine was given to children under 9 years of age.
“Sanofi’s Dengvaxia vaccine is only indicated for the population aged 9 and up, and up to 45,” the document says.
RECOMMENDATIONS ON THE DENGUE VACCINE
Given the risks of the dengue vaccine in minors, Cofepris asks health professionals to verify that the packaging is in Spanish, has a health record, batch number and expiration date.
“Likewise, these last data must coincide with those shown on the vial with the lyophilized powder. In addition, medical personnel are suggested to consult the attached instructions inside the packaging and review the Dengvaxia technical sheet available at gob.mx/cofepris,” the statement highlights.
Cofepris specifies that the Dengvaxia vaccine must be applied under medical assessment and supervision and reiterates that it should not be administered to children under 9 years of age, since it could represent a health risk.
WHAT IS DENGUE?
The Ministry of Health defines dengue as a disease caused by the virus (DENV) belonging to the Flaviviridae family, Falvivirus genus, made up of four serotypes (Denv-1, Denv-2, Denv-3 or Denv-4 virus) and that They are transmitted by the bite of female mosquitoes of the Ae species. aegypti and Ae. albopictus.
Symptoms usually last 2 to 7 days, and are characterized by fever, characteristic pain in the head (behind the eyes), general malaise, joint pain, muscle pain, redness in the skin, nausea, vomiting and loss of appetite. and in severe cases bleeding from the nose or gums, or bruising on the skin.
Treatment is aimed at relieving symptoms: rest, plenty of fluids, paracetamol to relieve fever, and hospitalization for severe cases.
Self-medication or the use of aspirin is not recommended due to the risk of bleeding and developing Reye’s Syndrome in children under 12 years of age, nor is the use of other non-steroidal anti-inflammatory drugs (naproxen, diclofenac, ketorolac, etc.) suggested.
2023-09-18 21:42:15
#Alert #vaccine #dengue
